Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study

Phase Ii ◽

Metastatic Breast ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

First Line Therapy ◽

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan

Anti-Cancer Drugs ◽

10.1097/cad.0b013e328302eb15 ◽

2008 ◽

Vol 19 (7) ◽

pp. 753-759 ◽

Cited By ~ 8

Author(s):

Nahomi Tokudome ◽

Yoshinori Ito ◽

Kiyohiko Hatake ◽

Masakazu Toi ◽

Muneaki Sano ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Pharmacokinetic Study ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

A Double-Blind, Randomized, Placebo-Controlled, Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib (SOR) in Combination with Paclitaxel (PAC) as a First-Line Therapy in Patients (pts) with Locally Recurrent or Metastatic Breast Cancer (BC).

10.1158/0008-5472.sabcs-09-44 ◽

2009 ◽

Cited By ~ 23

Author(s):

W. Gradishar ◽

V. Kaklamani ◽

T. Prasad Sahoo ◽

D. Lokanatha ◽

V. Raina ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

First Line Therapy ◽

Line Therapy ◽

Locally Recurrent

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

Clinical Breast Cancer ◽

10.1016/j.clbc.2018.12.012 ◽

2019 ◽

Vol 19 (2) ◽

pp. 105-112 ◽

Cited By ~ 2

Author(s):

Vanesa Ortega ◽

Antonio Antón ◽

Isabel Garau ◽

Noemia Afonso ◽

Lourdes Calvo ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Docetaxel versus epirubicin/cyclophosphamide (EC) as first-line therapy in metastatic breast cancer (MBC): Results from the randomized phase II TIPP study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.823 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 823-823

Author(s):

C. Wasemann ◽

A. Ertan ◽

C. Strunck ◽

W. Schmidt ◽

K. Diedrich ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3080 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3080-3080 ◽

Cited By ~ 4

Author(s):

F. Ciardiello ◽

T. Troiani ◽

F. Caputo ◽

M. de Laurentiis ◽

G. Tortora ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Three arm randomized parallel phase II/III study evaluating the efficacy and safety of the combinations Epirubicin and Taxotere® (ET), Taxotere® and Navelbine® (TN) and Navelbine® and Epirubicin (EN) as first line therapy in patients with metastatic breast cancer

http://isrctn.org/> ◽

10.1186/isrctn33132357 ◽

2013 ◽

Author(s):

E. Boven

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

BMC Cancer ◽

10.1186/1471-2407-5-151 ◽

2005 ◽

Vol 5 (1) ◽

Cited By ~ 15

Author(s):

Djelila Allouache ◽

Sulochana R Gawande ◽

Michele Tubiana-Hulin ◽

Nicole Tubiana-Mathieu ◽

Sophie Piperno-Neumann ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Locally Recurrent

Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdg199 ◽

2003 ◽

Vol 14 (5) ◽

pp. 699-703 ◽

Cited By ~ 5

Author(s):

I. Elomaa ◽

H. Joensuu ◽

C. Blomqvist

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii